The conservative management of Corynebacterium group D2 encrusted pyelitis

BJU International

Volumn 84, Issue 3, 1999, Pages 270-275

  Meria, P ^a,b   Desgrippes, A ^a   Fournier, R ^a   Arfi, C ^a   Antoine, C ^a   Martinat, L ^a   Teillac, P ^a   Le Duc, A ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Acidification; Corynebacterium group D2; Encrusted pyelitis; Percutaneous nephrostomy

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CREATININE; VANCOMYCIN;

ACIDIFICATION; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CORYNEBACTERIUM; CREATININE BLOOD LEVEL; ECHOGRAPHY; FEMALE; FEVER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY COLLECTING TUBULE; KIDNEY FAILURE; MALE; MYCOSIS; PAIN; PERCUTANEOUS NEPHROSTOMY; PRIORITY JOURNAL; PYELOGRAPHY; PYELONEPHRITIS; URETER CATHETER; URETER OBSTRUCTION; URINARY TRACT INFECTION; UROLITHIASIS;

EID: 0032790133     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1999.00156.x     Document Type: Article

References (36)

1. 1 Morales JM, Aguado JM, Diaz-Gonzalez R et al. Alkaline-encrusted pyelitis/cystitis and urinary tract infection due to Corynebacterium urealyticum: a new severe complication after renal transplantation. Transplant Proc 1992; 24: 81-2
2. 2 Aguado JM, Morales JM, Salto E et al. Encrusted pyelitis and cystitis by corynebacterium urealyticum (CDC Group D2): a new and threatening complication following renal transplant. Transplantation 1993; 56: 617-22
3. 3 Meignin V, Blanchet P, Quillard J et al. Pyelo-ureterite et cystite incrustée à Corynebacterium D2 chez un transplanté rénal. Ann Pathol 1996; 16: 45-8
4. 4 Soriano F, Aguado JM, Ponte C, Fernandez-Roblas R, Rodriguez-Tudela JL. Urinary tract infection caused by Corynebacterium Group D2: report of 82 cases and review. Rev Inf Dis 1990; 12: 1019-34
5. 5 Eschwege P, Hauk M, Blanchet P et al. Imaging analysis of encrusted cystitis and pyelitis in renal transplantation. Transplant Proc 1995; 27: 2444-5
6. 6 Maciejewski C, Boyer L, Carrie D et al. Calcifications pariétales du bassinet lors d'une infection urinaire par corynebacterium urealyticum. J Radiol 1996; 77: 571-3
7. 7 Soriano F, Ponte C, Santamaria M, Castilla C, Fernandez-Roblas R. In vitro and in vivo study of stone formation by corynebacterium group D2. J Clin Microbiol 1986; 23: 4691-4
8. 8 Aguado JM, Ponte C, Soriano F. Bacteriuria with a multiple resistant species of Corynebacterium (Corynebacterium group D2) an unnoticed cause of urinary tract infection. J Inf Dis 1987; 156: 144-50
9. 9 Soriano F, Rodriguez-Tudela JL, Fernandez-Roblas RJ, Aguado JM, Santamaria M. Skin colonisation by corynebacterium group D2 and JK in hospitalized patients. Clin Microbiol 1988; 26: 1878-80
10. 10 Garcia Bravo M, Aguado JM, Morales JM et al. Corynebacterium urealyticum en pacientes con transplante renal. Med Clin (Barc) 1995; 104: 561-4
11. 11 Arli C, Hoqueloux F, Vincent F et al. Récidive d'une insuffisance rénale aigue obstructive chez un patient atteint d'un lymphome pelvien. Rev Med Int 1996; 17: 282S-283S
12. 12 Benoit G, Blanchet P, Eschwege P, Alexandre L, Bensadoun H, Charpentier B. Insertion of a double pigtail ureteral stent for the prevention of urological complications in renal transplantation: a prospective randomized study. J Urol 1996; 156: 881-4
13. 13 Foulet A, Bendjaballah F, Manganella Meduri G et al. Maladie de Kaposi multiviscérale et pyelite incrustée chez un transplanté rénal. Ann Pathol 1996; 16: 453-6
14. 14 De Briel D, Langs JC, Rougeron G, Chabot P, Le Faou A. Multiresistant corynebacteria in bacteriuria: a comparative study of the role of Corynebacterium group D2 and Corynebacterium jeikeium. Hosp Infect 1991; 17: 35-43
15. 15 Nadler RB, Hoffman TA, Mc Clennan BL, Clayman RV. Corynebacterium urealyticum (CDC, group D2) associated with staghorn calculus: treatment by percutaneous debulking and chemolysis. J Endourol 1996; 10: 31-4
16. 16 Mulvaney WP. A new solvent for urinary calculi: a preliminary report. J Urol 1959; 82: 546-8
17. 17 Mulvaney WP, Henning DC. Solvent treatment of urinary calculi: refinements in technique. J Urol 1962; 88: 145-9
18. 18 Mulvaney WP. The hydrodynamics of renal irrigations: with reference to calculus solvents. J Urol 1963; 89: 768
19. 19 Dretler S. Pfister RC, Newhouse JH. Renal stone dissolution via percutaneous nephrostomy. N Eng J Med 1979; 300: 341-3
20. 20 Dretler S, Pfister RC. Primary dissolution therapy of struvite calculi. J Urol 1984; 131: 861-3
21. 21 Sant GR, Blaivas JG, Meares EM. Hemiacidrin irrigation in the management of struvite calculi: long-term results. J Urol 1983; 130: 1048-50
22. 22 Meria P, Desgrippes A, Arfi C, Le Duc A. Encrusted cystitis and pyelitis. J Urol 1998; 160: 3-9
23. 23 Marty N, Agueda L, Chabanon G. Adhérence et rôle pathogène des Corynebacterium groupe D2 isolés des urines. Rev Fr Laboratoires 1989; 195: 63-6
24. 24 Soriano F, Ponte C, Santamaria M, Fernandez-Roblas R. Struvite crystal formation by Corynebacterium group D2 in human urine and its prevention by acetohydroxamic acid. Eur Urol 1987; 13: 271-3
25. 25 Mhiri MN, Rebai T, Hammami A. La pyélo-urétérite incrustée. Ann Urol 1992; 26: 340-3
26. 26 Williams JJ, Rodman JS, Peterson CM. A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis. N Engl J Med 1984: 311: 760-4
27. 27 Griffith DP, Gleeson MJ, Lee H, Longuet R, Deman E. Earle N. Randomized double-blind trial of Lithostat (acetohydroxamic acid) in the palliative treatment of infection-induced urinary calculi. Eur Urol 1991; 20: 243-7
28. 28 Fostvedt GA, Barnes RW. Complications during lavage therapy for renal calculi. J Urol 1963; 89: 329-31
29. 29 Bagley DH. Pharmacologic treatment of infection stones. Urol Clin N Am 1987; 14: 347-52
30. 30 Marty N, Clave D, Cancet B, Henry-Ferry S, Didier J. Corynebacterium groupe D2. Etude clinique, identification biochimique et sensibilité aux antibiotiques. Pathol Biol 1988; 36: 460-4
31. 31 Cancet B, Gay JC, Tauriac S, Marty N, Clave D. Infections a Corynebacterium Groupe D2: Etude clinique et biochimique. Sensibilite aux antibiotiques. Med Mal Inf 1989; 19: 741-5
32. 32 Garcia-Rodriguez JA, Garcia-Sanchez JE, Munoz-Bellido JL, Nebreda-Mayoral T, Garcia Sannchez E, Garcia Garcia I. In vitro activity of 79 antimicrobial agents against Corynebacterium group D2, Antimicrobiol Agents Chemother 1991; 35: 2140-3
33. 33 Soriano F, Rodriguez-Tudela JL, Castilla C, Aviles P. Treatment of encrusted cystitis caused by Corynebacterium group D2 with norfloxacin, ciprofloxacin, and teicoplanin in an experimental model in rats. Antimicrobiol Agents Chemother 1991; 35: 2587-90
34. 34 Cunningham JJ, Friedland GW, Stamey TA. Radiologic changes in the urothelium during renacidin irrigations. J Urol 1973; 109: 556-8
35. 35 Aakura H, Selengut JD, Orme-Johnson WH, Dretler SP. The effect of calprotectin on the nucleation and growth of struvite crystals as assayed by light microscopy in real time. J Urol 1998; 159: 1384-9
36. 36 Grise P, Clotteau L, Martine E et al. Quelle solution acide et quelle cinétique apportent le meilleur pouvoir bactéricide sur les infections urinaires à Corynebacterium urealyticum ? Progrès Urol 1998; 8 (Suppl 1): 36A